Authorities in phage know-how and pet health and fitness be part of forces to acquire a new method for a frequent companion animal health and fitness issue
SAN FRANCISCO, Jan. 14, 2022 /PRNewswire/ — Felix Biotechnology — a biotechnology company centered on creating very first-in-class, accessible, antibacterial therapies to deal with drug-resistant bacterial infections — now announced it signed a partnership with AnimalBiome, a leader in pet wellbeing and wellness, to create new remedies to handle diarrhea in animals.
Specialists in phage technology and pet well being sign up for forces to create a new approach for companion animal well being fears
There is a expanding want for chemical-free and secure antimicrobial methods that selectively get rid of problematic bacteria even though preserving the effective microbes of the microbiome. Felix’s platform can be leveraged against a broad array of challenge bacterial species. The corporation has a number of on-likely partnerships to build phage-based methods with individual treatment and cosmetic firms, and this deal expands their footprint into animal well being.
Bacteriophage, or phage, are small viruses that infect and kill germs. By combining equipment learning and synthetic biology, Felix engineers phage to conquer the most important hurdles going through the broad adoption of phage technologies right now: slim spectrum and phage resistance.
“We are fully commited to obtaining a superior option for this typical affliction plaguing animals and distressing their homeowners,” claims Dr. Natalie Ma, Felix Cofounder and Head of BD at Felix. “By way of our unique technique to phage technologies, we will produce a secure, chemical-absolutely free, resilient and powerful treatment for this pernicious pathogen.”
“At AnimalBiome, we are concentrated on supplying new microbiome-concentrated answers to aid pets and their homeowners. Phage technology gives great assure in lowering the use of antibiotics in the treatment method of bacterial pathogens, preserving advantageous microbes, and supporting better health and fitness and wellness,” suggests Dr. Holly Ganz, CSO of AnimalBiome, “We are thrilled to get the job done with Felix to create new solutions exclusively created for pathogens afflicting companion animals.”
Primarily based in the San Francisco Bay Space and launched in 2016, AnimalBiome innovations pet wellness by intestine and oral microbiome investigate and products, and is generating a new class inside in the expanding $14 billion pet food stuff, supplement, and veterinary care marketplace. AnimalBiome was established by researchers who are passionate about pets and utilizes science to make improvements to animal wellbeing. AnimalBiome marketplaces and sells a spectrum of merchandise addressing digestive, pores and skin, and oral wellness, from screening to specific microbiome supplements to restore and retain pet wellness. Additional details is accessible at www.animalbiome.com.
About Felix Biotechnology
Felix Biotechnology is targeted on identifying, establishing and deploying customizable antimicrobials targeting urgent microbial threats. Felix’s discovery and engineering technological innovation platforms, crafted on technological innovation from Yale University and Lawrence Berkeley Countrywide Laboratory, make alternatives that triumph over the crucial limits of conventional antimicrobials to kill focused bacteria whilst preserving balanced microbiome purpose. Felix is a seed phase company funded by several buyers, which includes Y Combinator, Illumina Accelerator and Level72 Ventures. Far more data is accessible at www.felixbt.com.
Check out primary written content to obtain multimedia:https://www.prnewswire.com/news-releases/felix-biotechnology-to-collaborate-with-animalbiome-on-a-novel-answer-for-pet-diarrhea-301461382.html
Source Felix Biotechnology, Inc.